Jul 19, 2023 / 08:00PM GMT
Martin Gagel - Market Radius Research - Moderator
All right. Just some preliminary comments here, everyone. Thank you, firstly, for joining us. Jennifer will be presenting and discussing the business. I'll be asking some questions and we're digging into it a bit. And then at the end, we are taking questions from the audience.
We have received many questions already. We will go through those first and then we will I'll go through the questions that the audience puts in there. Probably at the bottom of your screen is a Q&A button, type in your questions. If we've addressed it, well, we'll skip over it, and we'll try to get through to everyone.
And then with that, I'm now going to start the official presentation. Jennifer, are we good?
Jennifer Bath - ImmunoPrecise Antibodies Ltd. - CEO
(inaudible)
Martin Gagel - Market Radius Research - Moderator
All right. And here we go. Good day. We've got CEO, Jennifer Bath, of ImmunoPrecise Antibodies joining us today, ImmunoPrecise is an antibody development
Immunoprecise Antibodies Ltd To Participate in an Interview Hosted by Market Radius Research Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot